Consultation on Dual-Use in Life Science Research

From Public Health Agency of Canada

Current status: OPEN

Open on June 29, 2018 and will close to new input on November 29, 2018.

The Public Health Agency of Canada (PHAC) and Canadian Food Inspection Agency (CFIA) have launched a public consultation on the new Canadian Biosafety Guideline: Dual-Use in Life Science Research.

How to participate

Review the draft Canadian Biosafety Guideline: Dual-Use in Life Science Research and submit your feedback and comments to the PHAC.

Send us an email

Send an email to PHAC.pathogens-pathogenes.ASPC@canada.ca with your feedback or comments.

Participate by mail

Send a letter with your feedback and comments to the address in the contact us section.

All comments must be received by November 29, 2018.

Who is the focus of this consultation

This consultation is intended for:

  • Researchers in life sciences
  • Biosafety professionals
  • Biosecurity professionals
  • Licence holders and applicants for a Pathogen and Toxin Licence
  • Individuals who have imported an animal pathogen under an animal pathogen import
  • Members of the public with an interest in the subject matter

Goals of the consultation

The Guideline is intended to increase awareness on dual-use and promote the responsible conduct of research amongst the scientific and biosafety community. It was developed by the PHAC and the CFIA, in consultation with subject matter experts. Given that the concept of dual-use in life science research is relatively new, the PHAC and the CFIA are striving to achieve clarity and usability of the Guideline. Feedback will be used to improve upon the Guideline so that it enables users to identify, assess, and mitigate the risks associated with research with dual-use potential. Questions to be considered when reviewing and providing feedback and comments on the Guideline:

  • Is the concept and definition of dual-use clear? How could this be improved?
  • Are the roles and responsibilities with respect to the identification, assessment, and mitigation of risks clear? How could this be improved?
  • Is the material presented in a logical manner and does it aid in learning and understanding? How could this be improved?
  • Is there any material that should be added and/or removed?

Related information (optional)

Contact us

Email: PHAC.pathogens-pathogenes.ASPC@canada.ca

Public Health Agency of Canada
100 Colonnade Road
Ottawa, ON K1A 0K9

Telephone: 613-957-1779
Fax: 613-941-0596

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: